Skip to main content
OpenTrials

Clinical trial condition

Puberty, Precocious

Explore clinical trials studying Puberty, Precocious. Study availability and eligibility vary by location and protocol.

54 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Puberty, Precocious trial results

Completed

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]

NCT00094328

Conditions
Endocrine System Diseases, Familial Testotoxicosis, Gonadal Disorders, +1 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Minneapolis, Minnesota, United States
View all 15 locations
View Trial Details
Completed

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

NCT01467882

Conditions
Central Precocious Puberty, Endocrine System Diseases, Gonadal Disorders, +1 more
Locations
  • Pediatric Endocrinology of Phoenix Phoenix, Arizona, United States
  • Children's National Medical Center San Diego, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Arnold Palmer Pediatric Endocrinology Practice Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

NCT00667446

Conditions
Central Precocious Puberty (CPP), Depot Formulation, Endocrine System Diseases, +12 more
Locations
  • Site Reference ID/Investigator# 13521 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 14922 Long Beach, California, United States
  • Site Reference ID/Investigator# 26043 Los Angeles, California, United States
  • Site Reference ID/Investigator# 20802 San Diego, California, United States
View all 20 locations
View Trial Details
Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

NCT00635817

Conditions
Endocrine System Diseases, Gonadal Disorders, Puberty, Precocious
Locations
  • Site Reference ID/Investigator# 8765 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 11522 Long Beach, California, United States
  • Site Reference ID/Investigator# 8756 Los Angeles, California, United States
  • Site Reference ID/Investigator# 8755 San Diego, California, United States
View all 25 locations
View Trial Details
Completed

Study of Lupron Depot In The Treatment of Central Precocious Puberty

NCT00660010

Conditions
Endocrine System Diseases, Gonadal Disorders, Puberty, Precocious
Locations
  • Site Reference ID/Investigator# 46673 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 46671 San Francisco, California, United States
  • Site Reference ID/Investigator# 14921 Stanford, California, United States
  • Site Reference ID/Investigator# 14343 Aurora, Colorado, United States
View Trial Details

Related conditions